Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Bair Teresa Brophy. Officer active across 1 company, notably Kura Oncology, Inc.. Aggregated, 14 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €553k. History available since 17 November 2022. The latest transaction was disclosed on 19 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bair Teresa Brophy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
31,487 shares@ US$12.63Common StockSEC:0001193125-26-361184:0
4,096 shares@ US$8.460713.9% of flowCommon StockSEC:0001193125-26-025301:0
50,000 shares0Common StockSEC:0001193125-26-004562:0
48,900 shares0Common StockSEC:0001193125-25-283568:0
48,900 shares0Common StockSEC:0001193125-25-223666:0
1,559 shares@ US$5.964.6% of flowCommon StockSEC:0000950170-25-074660:0
2,437 shares@ US$7.871910.2% of flowCommon StockSEC:0000950170-25-010120:0
4,844 shares@ US$7.871920.2% of flowCommon StockSEC:0000950170-25-010120:1
46,250 shares0Common StockSEC:0000950170-25-002062:0
2,615 shares@ US$22.147729.5% of flowCommon StockSEC:0000950170-24-062585:0
2,053 shares@ US$17.800518.6% of flowCommon StockSEC:0000950170-24-009495:0
46,250 shares0Common StockSEC:0000950170-24-001847:0
23,125 shares0Common StockSEC:0001209191-23-011287:0
2,100 shares@ US$15.221217.0% of flowCommon StockSEC:0001209191-22-057874:0
About Bair Teresa Brophy
Bair Teresa Brophy is a declarant linked to Kura Oncology, Inc., where she is Chief Legal Officer. Across 13 total filings, the 13 sampled filings cover the period from 2022-11-18 to 2026-01-27 and show EUR 0 in buys and EUR 210101 in sells, with the modal transaction nature listed as Cession.